Ortivus AB ser. A (ORTI-A) - Total Liabilities
Based on the latest financial reports, Ortivus AB ser. A (ORTI-A) has total liabilities worth Skr47.71 Million SEK (≈ $5.13 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Ortivus AB ser. A equity growth rate to track the company's year-over-year net asset growth rate.
Ortivus AB ser. A - Total Liabilities Trend (2003–2025)
This chart illustrates how Ortivus AB ser. A's total liabilities have evolved over time, based on quarterly financial data. See Ortivus AB ser. A (ORTI-A) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Ortivus AB ser. A Competitors by Total Liabilities
The table below lists competitors of Ortivus AB ser. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fashion Bel Air S.A
PA:ALFBA
|
France | €5.19 Million |
|
H&G High Conviction Ltd
AU:HCF
|
Australia | AU$22.20K |
|
Medivie Therapeutic Ltd
TA:MDVI
|
Israel | ILA9.13 Million |
|
New Destiny Mining Corp
V:NED
|
Canada | CA$2.49 Million |
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
UK | GBX3.65 Million |
|
in Style Group PLC
LSE:ITS
|
UK | GBX18.59 Million |
|
Quintegra Solutions Limited
NSE:QUINTEGRA
|
India | Rs142.76 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Ortivus AB ser. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ORTI-A market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ortivus AB ser. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ortivus AB ser. A (2003–2025)
The table below shows the annual total liabilities of Ortivus AB ser. A from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr48.52 Million ≈ $5.22 Million |
-31.74% |
| 2024-12-31 | Skr71.07 Million ≈ $7.65 Million |
+28.29% |
| 2023-12-31 | Skr55.40 Million ≈ $5.96 Million |
+2.00% |
| 2022-12-31 | Skr54.31 Million ≈ $5.85 Million |
+26.27% |
| 2021-12-31 | Skr43.02 Million ≈ $4.63 Million |
-8.23% |
| 2020-12-31 | Skr46.87 Million ≈ $5.04 Million |
+79.00% |
| 2019-12-31 | Skr26.19 Million ≈ $2.82 Million |
+2.63% |
| 2018-12-31 | Skr25.52 Million ≈ $2.75 Million |
+34.40% |
| 2017-12-31 | Skr18.98 Million ≈ $2.04 Million |
-54.82% |
| 2016-12-31 | Skr42.02 Million ≈ $4.52 Million |
-21.72% |
| 2015-12-31 | Skr53.68 Million ≈ $5.78 Million |
-15.40% |
| 2014-12-31 | Skr63.46 Million ≈ $6.83 Million |
+224.27% |
| 2013-12-31 | Skr19.57 Million ≈ $2.11 Million |
-11.07% |
| 2012-12-31 | Skr22.00 Million ≈ $2.37 Million |
+0.01% |
| 2011-12-31 | Skr22.00 Million ≈ $2.37 Million |
+32.86% |
| 2010-12-31 | Skr16.56 Million ≈ $1.78 Million |
-79.17% |
| 2009-12-31 | Skr79.50 Million ≈ $8.56 Million |
+6.34% |
| 2008-12-31 | Skr74.76 Million ≈ $8.05 Million |
-17.32% |
| 2007-12-31 | Skr90.42 Million ≈ $9.73 Million |
-16.17% |
| 2006-12-31 | Skr107.87 Million ≈ $11.61 Million |
-14.76% |
| 2005-12-31 | Skr126.55 Million ≈ $13.62 Million |
+267.92% |
| 2004-12-31 | Skr34.40 Million ≈ $3.70 Million |
-7.77% |
| 2003-12-31 | Skr37.29 Million ≈ $4.01 Million |
-- |
About Ortivus AB ser. A
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more